Cytotoxic T-lymphocyte (CTL) precursor frequency in peripheral blood of patients before and after CTL infusion
| Patient . | Before infusion . | Post-I dose 2 wk . | Post-I dose 4 wk . | Post-II dose 2 wk . | Post-II dose 8 wk . | Post-III dose 2 wk . | Post-III dose 12 wk . |
|---|---|---|---|---|---|---|---|
| 4 | 1/37 658 | 1/40 689 | — | 1/22 094 | 1/27 075 | 1/20 787 | 1/22 276 |
| 5 | 1/15 764 | — | — | 1/10 069 | — | 1/6 243 | 1/6 209 |
| 6 | 1/832 786 | 1/23 845 | 1/28 210 | 1/30 454 | 1/28 230 | — | — |
| 7 | 1/64 040 | 1/42 785 | — | 1/45 067 | — | — | — |
| Patient . | Before infusion . | Post-I dose 2 wk . | Post-I dose 4 wk . | Post-II dose 2 wk . | Post-II dose 8 wk . | Post-III dose 2 wk . | Post-III dose 12 wk . |
|---|---|---|---|---|---|---|---|
| 4 | 1/37 658 | 1/40 689 | — | 1/22 094 | 1/27 075 | 1/20 787 | 1/22 276 |
| 5 | 1/15 764 | — | — | 1/10 069 | — | 1/6 243 | 1/6 209 |
| 6 | 1/832 786 | 1/23 845 | 1/28 210 | 1/30 454 | 1/28 230 | — | — |
| 7 | 1/64 040 | 1/42 785 | — | 1/45 067 | — | — | — |